What is HHC resin?
HHC , or hexahydrocannabinol, is a synthetic cannabinoid obtained by hydrogenating THC ( tetrahydrocannabinol ). This molecule is very similar to THC, the main psychoactive substance in cannabis that gives it its psychotropic properties. Unlike THC and CBD ( cannabidiol), which are natural phytocannabinoids found in the cannabis plant, HHC is a synthetic substance manufactured in a laboratory.
The different forms of HHC
HHC can be found in various forms, such as:
- HHC resin
- HHC flowers
- HHC oil
- HHC-based candies
Legal ambiguity surrounding HHC in France
Currently, hepatitis C is not listed as a narcotic in France. Therefore, it is not subject to a sales ban, unlike in other European countries such as Finland and Austria. However, this situation could soon change, as French health authorities are concerned about the sale of hepatitis C in shops and online.
Where can I get HHC in France before it's banned?
For the time being, it is still possible to buy HHC over the counter in some shops and on websites offering CBD products. However, this situation is unlikely to last, as a ban on the sale and consumption of HHC is imminent.
The future of HHC in France
Please note that since June 12, 2023, HHC is banned in France
The decision to ban the sale and consumption of HHC in France raises several questions about the future of this synthetic cannabinoid in the country. While some believe this measure is necessary to protect public health, others are concerned about the potential consequences for the cannabis and cannabis-derived products market.
In conclusion, HHC resin and other hexahydrocannabinol-based products are currently available for sale without a prescription in France, but their legal status is about to change. Health authorities are concerned about the potential effects of this synthetic molecule on consumers' health and are therefore considering banning it soon. It is therefore recommended to remain cautious regarding HHC consumption and to stay informed of upcoming legislative developments.
Editor-in-Chief specializing in CBD
Julien, born on July 17, 1978, in the Paris region, is a prominent writer and expert in the field of CBD products. Following his studies, Julien developed a passion for natural remedies, including CBD. In 2022, he joined the CBD.fr team as an expert and regular contributor. Thanks to his scientific expertise and clear writing style, Julien helps demystify the complexities of CBD, while highlighting its benefits and potential applications through his articles and conference presentations.
